Synthesis and anti-HBV evaluation of mono L-amino acid ester, mono non-steroid anti-inflammation drug carboxylic ester derivatives of acyclonucleoside phosphonates

[1]  Y. Liu,et al.  Synthesis, anti-HBV activity and renal cell toxicity evaluation of mixed phosphonate prodrugs of adefovir. , 2012, European journal of medicinal chemistry.

[2]  Yushe Yang,et al.  Design, synthesis and in vitro evaluation of mono (2, 2, 2-trifluoroethyl) esters, mono l-amino acid ester prodrugs of acyclic nucleoside phosphonates as anti-HBV agents , 2011 .

[3]  M. Sofia,et al.  Adenosine deaminase-like protein 1 (ADAL1): characterization and substrate specificity in the hydrolysis of N(6)- or O(6)-substituted purine or 2-aminopurine nucleoside monophosphates. , 2011, Journal of medicinal chemistry.

[4]  L. Haragsim,et al.  Nephrotoxicity as a complication of antiretroviral therapy. , 2006, Advances in chronic kidney disease.

[5]  E. Clercq,et al.  Acyclic nucleoside phosphonates: a key class of antiviral drugs , 2005, Nature Reviews Drug Discovery.

[6]  M. Yuen,et al.  Adefovir dipivoxil in chronic hepatitis B infection , 2004, Expert opinion on pharmacotherapy.

[7]  E. Clercq.  Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections , 2003 .

[8]  R. Hamatake,et al.  Agents in clinical development for the treatment of chronic hepatitis B , 2003, Expert opinion on investigational drugs.

[9]  Y. Iwase,et al.  Antiviral Activities of MCC-478, a Novel and Specific Inhibitor of Hepatitis B Virus , 2002, Antimicrobial Agents and Chemotherapy.

[10]  Y. Shiratori,et al.  Novel Nucleoside Analogue MCC-478 (LY582563) Is Effective against Wild-Type or Lamivudine-Resistant Hepatitis B Virus , 2002, Antimicrobial Agents and Chemotherapy.

[11]  S. Nigam,et al.  The organic anion transporter family: from physiology to ontogeny and the clinic. , 2001, American journal of physiology. Renal physiology.

[12]  T. Cihlar,et al.  Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. , 2000, The Journal of pharmacology and experimental therapeutics.

[13]  T. Cihlar,et al.  Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. , 2000, Journal of the American Society of Nephrology : JASN.

[14]  G. Acs,et al.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.